Clinical Trial Update: Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating the combination of bendamustine hydrochloride, bortezomib, and dexamethasone in newly diagnosed multiple myeloma has completed enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (dexamethasone) (dexamethasone)
• Treanda (bendamustine hydrochloride) (bendamustine)
• Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-07